In the CORIST Study beneficial effects of NOAC treatment in patients with AF admitted due to COVID-19 were also observed but did not reach statistical significance, probably due to low number of patients with AF ( n = 154, 3.5%) ( 18 ).
← all excerpts
Prevalence and clinical implications of atrial fibrillation in patients hospitalized due to COVID-19: Data from a registry in Poland.
1
—
—